Clinical Trial

Genetic Study of Amyotrophic Lateral Sclerosis in Norway

Study acronym: GAIN
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-11-02; most recent amendment 2026-05-18.
Status change: Enrolling by Invitation → Recruiting 2025-01-06
Trial Details
NCT Number NCT05119387
Lead Sponsor Sykehuset Telemark
Collaborators: ALS Norge, Helse Sor-Ost
Conditions Amyotrophic Lateral Sclerosis
Enrollment 1,200 participants
Start Date 2019-08-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-19